Novanta Inc (NOVTU) — SEC Filings
Novanta Inc (NOVTU) — 28 SEC filings. Latest: 8-K (Dec 1, 2025). Includes 15 8-K, 5 10-Q, 3 SC 13G/A.
Overview
Novanta Inc (NOVTU) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 1, 2025: On December 1, 2025, Novanta Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 125 Middlesex Turnpike, Bedford, Massachusetts 01730. The company's former name was GSI Group Inc., with a name change date of June 22, 2005.
Sentiment Summary
Across 28 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 26 neutral. The dominant filing sentiment for Novanta Inc is neutral.
Filing Type Overview
Novanta Inc (NOVTU) has filed 15 8-K, 5 10-Q, 2 DEF 14A, 2 10-K, 3 SC 13G/A, 1 SC 13G with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (28)
Risk Profile
Risk Assessment: Of NOVTU's 23 recent filings, 1 were flagged as high-risk, 9 as medium-risk, and 13 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $722.25M |
| Net Income | $36.36M |
| Cash Position | $89.22M |
| Total Debt | $445.66M |
Key Executives
- Robert J. Donoghue
- David R. Johnson
- David M. D'Amico
- Michael J. McGovern
- David M. McIntosh
- Dr. Robert J. P. Smith
- Sarah B. D. Segal
- Robert J. Donahue
- Robert J. Blair
Industry Context
Novanta operates as a global supplier of core technology solutions for medical and advanced industrial OEMs. The company leverages expertise in precision medicine, robotics, automation, and advanced surgery. Key trends include the increasing demand for precision and performance in medical devices and industrial automation, driven by technological advancements and regulatory requirements.
Top Tags
financials (4) · filing-update (3) · 10-Q (3) · corporate-action (2) · financial-obligation (2) · executive-change (2) · debt (2) · corporate-governance (2) · shareholder-vote (2) · executive-compensation (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Income (Q3 2025) | $10.65M | Decreased 44.5% from $19.19M in Q3 2024 |
| Net Income (9 Months 2025) | $36.36M | Decreased 23.6% from $47.62M in 9 Months 2024 |
| Revenue (Q3 2025) | $247.84M | Increased 1.4% from $244.41M in Q3 2024 |
| Operating Income (9 Months 2025) | $69.18M | Decreased 17.5% from $83.88M in 9 Months 2024 |
| Restructuring, Acquisition, and Related Costs (Q3 2025) | $6.68M | Increased 167.2% from $2.50M in Q3 2024 |
| Net Cash Provided by Operating Activities (9 Months 2025) | $55.25M | Decreased 43% from $96.95M in 9 Months 2024 |
| Cash and Cash Equivalents (Sept 26, 2025) | $89.22M | Decreased from $113.99M at Dec 31, 2024 |
| Long-term Debt (Sept 26, 2025) | $445.66M | Increased from $411.95M at Dec 31, 2024 |
| Repurchases of Common Shares (9 Months 2025) | $20.21M | Significant cash outflow in financing activities |
| Q2 2025 Revenue | $250.5M | Up 8.9% from $230.1M in Q2 2024 |
| Q2 2025 Net Income | $35.2M | Up 23.5% from $28.5M in Q2 2024 |
| Q2 2025 Diluted EPS | $0.98 | Increased from $0.80 in Q2 2024 |
| Medical Solutions Revenue Growth | 12.1% | Segment revenue reached $120.3M in Q2 2025 |
| Automation & Enabling Technologies Revenue Growth | 6.5% | Segment revenue reached $130.2M in Q2 2025 |
| Keonn Technologies S.L. Acquisition Cost | $25.0M | Completed on April 8, 2025, expanding RFID capabilities |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Novanta Inc (NOVTU)?
Novanta Inc has 28 recent SEC filings from Jan 2024 to Dec 2025, including 15 8-K, 5 10-Q, 3 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of NOVTU filings?
Across 28 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 26 neutral. The dominant sentiment is neutral.
Where can I find Novanta Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Novanta Inc (NOVTU) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Novanta Inc?
Key financial highlights from Novanta Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for NOVTU?
The investment thesis for NOVTU includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Novanta Inc?
Key executives identified across Novanta Inc's filings include Robert J. Donoghue, David R. Johnson, David M. D'Amico, Michael J. McGovern, David M. McIntosh and 4 others.
What are the main risk factors for Novanta Inc stock?
Of NOVTU's 23 assessed filings, 1 were flagged high-risk, 9 medium-risk, and 13 low-risk.
What are recent predictions and forward guidance from Novanta Inc?
Forward guidance and predictions for Novanta Inc are extracted from SEC filings as they are enriched.